Skip to navigation Skip to main content
Cancer Therapy Advisor
  • Breast
  • CML
  • Gastrointestinal
  • GYN
  • Lung
  • Multiple Myeloma
  • Prostate
  • RCC
  • Skin
  • More
    • More
      • Bladder Cancer
      • Bone Cancer
      • Brain Cancer
      • Chronic Lymphocytic Leukemia
      • Endocrine Cancer
      • General Medicine
      • General Oncology
      • Head and Neck Cancer
      • Hematologic Cancers
      • Lymphoma
      • Pancreatic Cancer
      • Pediatric Cancer
      • Practice Management
      • Sarcoma
      • Supportive Care
      • Urologic Cancers
  • Headlines
  • Regimens
  • Drugs
  • Conferences
  • Clinical Resources
  • Tools
  • Multimedia
  • CME
  • Jobs
  • Get the App
  • Submit Cases

Home » News » Conference Coverage » American Society of Clinical Oncology (ASCO) » ASCO 2014

Publish Date May 31, 2014

Dr. Hudis Becomes First ASCO President to Tweet Presidential Address

  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Reddit
  • Print
  • Share by Email
[View the story “#ASCO14: Dr. Hudis Offers Vision for Future of Medicine” on Storify]

Topics:

Conference Coverage General Oncology

Related Articles

  • Bladder Tumor Mutations May ID Responders to Everolimus

    Ridaforolimus + AKT Inhibitor Phase 1 Trial: Tolerable but Modest Efficacy for Breast Cancer

  • Researchers ID Toxins Linked to Breast Cancer

    Shared Decision-making Ups Clinical Trial Participation, But Few Still Enroll

  • Loading...

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next post in ASCO 2014
Bladder Tumor Mutations May ID Responders to Everolimus

Ridaforolimus + AKT Inhibitor Phase 1 Trial: Tolerable but Modest Efficacy for Breast Cancer

Back to Top
  • CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients.

    Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions.

  • Resources
    • Submissions
    • Advisory Board
    • Useful Links
    • Reprints/Permissions
  • User Center
    • About Us
    • Advertise
    • Contact Us
    • Staff
  • Other Haymarket Medical Websites
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • McKnight’s Long Term Care News
    • McKnight’s Senior Living
    • Medical Bag
    • MPR
    • myCME
    • Neurology Advisor
    • Oncology Nurse Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
  • Copyright © 2023 Haymarket Media, Inc. All Rights Reserved
    This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
    Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

Loading...
Loading...
Loading...
Loading...